Melih Şimşek
Impact in
-
- Inflammatory Biomarkers in Disease Prognosis
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
-
- Advanced Breast Cancer Therapies
- Brain Metastases and Treatment
Papers in
-
- Gastric Cancer Management and Outcomes 5
- Advanced Breast Cancer Therapies 4
- Lung Cancer Treatments and Mutations 3
- Oncology 14
- Inflammatory Biomarkers in Disease Prognosis 3
- COVID-19 and healthcare impacts 3
- Co-authors
- Mehmet Bilici (8 shared papers)Salim Başol Tekin (10 shared papers)Hacı Mehmet Türk (12 shared papers)Mesut Şeker (10 shared papers)Mehmet Türkeli (5 shared papers)Pinar SOYSAL (2 shared papers)Ahmet Berhan Yılmaz (1 shared paper)Erkan Dervişoğlu (1 shared paper)
In The Last Decade
Melih Şimşek
32 papers receiving 273 citations
Peers
Comparison fields: 5 of 63
- Oncology 110
- Pulmonary and Respiratory Medicine 51
- Cancer Research 23
- Geriatrics and Gerontology 5
- Genetics 14
Countries citing papers authored by Melih Şimşek
This map shows the geographic impact of Melih Şimşek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melih Şimşek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melih Şimşek more than expected).
Fields of papers citing papers by Melih Şimşek
This network shows the impact of papers produced by Melih Şimşek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melih Şimşek. The network helps show where Melih Şimşek may publish in the future.
Co-authors
The 25 scholars most cited alongside Melih Şimşek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 39 | |
| 2 | 2015 | 33 | |
| 3 | 2022 | 22 | |
| 4 | 2023 | 15 | |
| 5 | 2021 | 15 | |
| 6 | 2022 | 15 | |
| 7 | 2021 | 14 | |
| 8 | 2020 | 13 | |
| 9 | 2023 | 11 | |
| 10 | 2018 | 10 | |
| 11 | 2024 | 10 | |
| 12 | 2011 | 9 | |
| 13 | 2021 | 8 | |
| 14 | 2025 | 7 | |
| 15 | 2014 | 7 | |
| 16 | 2023 | 6 | |
| 17 | 2003 | 6 | |
| 18 | 2022 | 5 | |
| 19 | 2023 | 5 | |
| 20 | 2019 | 4 |
About Melih Şimşek
Melih Şimşek is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pathology and Forensic Medicine and Genetics, having authored 43 papers that have together received 278 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (5 papers), Advanced Breast Cancer Therapies (4 papers), Inflammatory Biomarkers in Disease Prognosis (3 papers), Breast Cancer Treatment Studies (3 papers), Glioma Diagnosis and Treatment (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Lung Cancer Treatments and Mutations (3 papers) and COVID-19 and healthcare impacts (3 papers). The work is most often cited by research in Oncology (110 citations), Pulmonary and Respiratory Medicine (51 citations), Cancer Research (23 citations), Geriatrics and Gerontology (5 citations) and Genetics (14 citations). Melih Şimşek has collaborated with scholars based in Türkiye, Australia and Poland. Frequent co-authors include Mehmet Bilici, Salim Başol Tekin, Hacı Mehmet Türk, Mesut Şeker, Mehmet Türkeli, Pinar SOYSAL, Ahmet Berhan Yılmaz, Erkan Dervişoğlu, Ali Yılmaz and Fırat Kardelen. Their work appears in journals such as Future Oncology, Fetal Diagnosis and Therapy, Supportive Care in Cancer, Annals of Oncology and Cancer Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.